Can be used as a concept of internet paid medicine, digital financial security, etc. Stock photograph of a young Asian woman conducting a seminar / lecture with the aid of a large screen. The screen ...

Experts have issued a warning after a woman lost her hair following an insect bite. The 28-year-old, from Boston, ...

The anti-diabetic drug Ozempic has become popular for weight loss, prompting debates among celebrities and health experts.

Telix’s CEO for precision medicine Kevin Richardson says the ruling ... CLE creates real-time digital microscopic images at a magnification 1000 times that of traditional scans and avoids the need for ...

The FDA’s tardiness in approving the nuclear medicine device is a tad puzzling ... after which they are eventually dispersed through breathing. Technegas images the fine alveoli, where the oxygen and ...

Barclays dropped their target price on Editas Medicine from $7.00 to $5.00 and set an “equal weight” rating on the stock in a research report on Tuesday. Bank of America raised shares of ...

On the financial front, Disc Medicine announced a public stock offering of approximately $178 million, led by Frazier Life Sciences and Logos Capital, to advance research and clinical development ...

The upgrade to Outperform reflects the firm's positive outlook on the stock's potential, based on the detailed financial analysis and the underlying value of Editas Medicine's technology and assets.

In this article, we are going to take a look at where Editas Medicine, Inc. (NASDAQ ... we can outperform the market by imitating the top stock picks of the best hedge funds.

Is Colorado's Cannabis Market Back On Track? A 5% Sales Boost Says Yes The Colorado Department of Revenue reported 673 cannabis dispensaries by the end of August, with an average revenue of $ ...

Residents of the countries of the European Union are recommended to stock up on at least three days' worth of ... These include supplies of food, drink and medicine, a flashlight and a battery-powered ...

Jefferies initiated its coverage of hematology-focused biotech Disc Medicine (NASDAQ:IRON) with a buy recommendation on Wednesday, citing the potential of its lead candidate, bitopertin ...